Evidence map›Paper›PMID 39859729›Full record

ArticleMaterials (Basel, Switzerland)2025

Magnetite Nanoparticles Encapsulated with PBS-PEG for AMF Hyperthermia.

Carlos Augusto Zanoni Souto, Fernando Gomes de Souza Junior, André Romero da Silva, Kaushik Pal

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carlos Augusto Zanoni SoutoInstituto de Macromoléculas Professora Eloisa Mano, Centro de Tecnologia-Cidade Universitária, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.ORCID 0000-0001-6895-0764
Fernando Gomes de Souza JuniorInstituto de Macromoléculas Professora Eloisa Mano, Centro de Tecnologia-Cidade Universitária, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.ORCID 0000-0002-8332-4953
André Romero da SilvaDepartamento de Química, Federal Institute of Espírito Santo, Campus Aracruz, Avenida Morobá, 248, Aracruz 29192-733, Brazil.
Kaushik PalUniversity Centre for Research and Development (UCRD), Department of Physics, Chandigarh University, Mohali 140413, Punjab, India.ORCID 0000-0002-9313-6497

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel studies on typical synthesized magnetite nanoparticles were encapsulated into a poly (butylene succinate)/poly (ethylene glycol) copolymer (PBS-PEG). PBS was chosen because of its biocompatibility characteristics necessary for biomedical applications. PEG, as part of the macromolecular structure, increases the hybrid system's solubility in an aqueous environment, increasing the circulation time of the material in the bloodstream. The immune system has difficulty recognizing particles with good solubility in an aqueous medium and with a diameter until 200 nm, preventing the body from eliminating the nanoparticles before the magnetic hyperthermia is performed. All the prepared materials were characterized by Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), X-ray powder diffraction (XRD), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), dynamic light scattering (DLS), and zeta potential. The detailed investigated result executes the formulation developed in this work, showing it has potential and that further studies and analyses can be carried out so that the formulation can be improved, thus obtaining even better results.

Indexed as

cancerhyperthermiamagnetitenanoparticulate carrierspolymer

Identifiers

PMID39859729
PMCPMC11766469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.